
 
													 
									 
															 
															Year
 
															DEALS // DEV.
 
															Country
 
															 
															Therapeutic Area
 
															Study Phase
 
															Deal Type
 
															Product Type
 
															Dosage Form
 
															Lead Product
 
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Rabies Vaccine, Human
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Recipient : Vietnam Military Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Rabivax-S (Rabies Vaccine, Human) is a Vaccine drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Rabies.
Product Name : Rabivax-S
Product Type : Vaccine
Upfront Cash : Inapplicable
July 10, 2023
Lead Product(s) : Rabies Vaccine, Human
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Recipient : Vietnam Military Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Vietstar Biomedical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) is a Vaccine drug candidate, which is currently being evaluated in clinical studies for the treatment of Streptococcus pneumoniae.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
December 01, 2021
Lead Product(s) : Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Vietstar Biomedical Research
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Live Varicella Virus Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Recipient : Vietnam Military Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Skyvaricella (Live Varicella Virus Vaccine) is a Vaccine drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Chickenpox.
Product Name : Skyvaricella
Product Type : Vaccine
Upfront Cash : Inapplicable
May 12, 2020
Lead Product(s) : Live Varicella Virus Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Recipient : Vietnam Military Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery
Sponsor : Vingroup Innovation Foundation
Deal Size : $0.3 million
Deal Type : Funding
Vietnam’s Vingroup funds three coronavirus research projects
Details : With this funding, Vabiotech will be developing vaccines against the novel coronavirus (Covid-19) on growing medium of Baculoviruses at laboratory scale led by Dr. Do Tuan Dat.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
February 21, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery
Sponsor : Vingroup Innovation Foundation
Deal Size : $0.3 million
Deal Type : Funding

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Vietstar Biomedical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : This is a Vaccine drug candidate, which is currently being evaluated in clinical studies for the treatment of Diphtheria.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
April 30, 2019
Lead Product(s) : Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Vietstar Biomedical Research
Deal Size : Inapplicable
Deal Type : Inapplicable

 Reset All
Reset All